Comparison of Recovery Profiles Among Propofol, Remimazolam, and Dexmedetomidine After Intraoperative Sedation

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

February 23, 2023

Primary Completion Date

August 12, 2023

Study Completion Date

August 13, 2023

Conditions
RemimazolamPropofolDexmedetomidineOrthopedic ProceduresSedativesBrachial Plexus Block
Interventions
DRUG

Remimazolam

The patient receives continuous infusion of remimazolam at a rate of 0.3-1.0 mg/kg/hr.

DRUG

Propofol

Patients are administered propofol at an effective site concentration of 1.0-2.5 mcg/ml through target-controlled infusion.

DRUG

Dexmedetomidine

The patient is administered a dose of dexmedetomidine at 1 mcg/kg for 10 minutes, followed by continuous infusion at a rate of 0.2-1.0 mcg/kg/hr.

Trial Locations (1)

05505

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT05688345 - Comparison of Recovery Profiles Among Propofol, Remimazolam, and Dexmedetomidine After Intraoperative Sedation | Biotech Hunter | Biotech Hunter